ArticleOncoTargets and therapy2017

HIF pathway and c-Myc as biomarkers for response to sunitinib in metastatic clear-cell renal cell carcinoma.

P Maroto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.